Pyridine → 3-(3-Methyl-1,2,4-thiadiazol-5-yl)-6-[[4-[3-(trifluoromethyl)phenoxy]butyl]thio]pyridazine
反応式
C[N:2](C)[C:3](=[N:5][C:6]([C:8]1[N:9]=[N:10][C:11]([S:14][CH2:15][CH2:16][CH2:17][CH2:18][O:19][C:20]2[CH:25]=[CH:24][CH:23]=[C:22]([C:26]([F:29])([F:28])[F:27])[CH:21]=2)=[CH:12][CH:13]=1)=[S:7])[CH3:4].N1C=CC=CC=1.NOS(O)(=O)=O>C(O)C.CO>[CH3:4][C:3]1[N:5]=[C:6]([C:8]2[N:9]=[N:10][C:11]([S:14][CH2:15][CH2:16][CH2:17][CH2:18][O:19][C:20]3[CH:25]=[CH:24][CH:23]=[C:22]([C:26]([F:29])([F:28])[F:27])[CH:21]=3)=[CH:12][CH:13]=2)[S:7][N:2]=1参加物
実験手順
A mixture of intermediate 13 (0.009 mol) and pyridine (0.02 mol) in ethanol (80 ml) was stirred. A mixture of hydroxylamine-O-sulfonic acid (0.01 mol) in methanol (20 ml) was added. The mixture was stirred overnight. The solvent was evaporated. The residue was taken up in DCM. The organic solution was washed with a diluted NaOH solution and with water, dried, filtered and the solvent was evaporated. The residue was purified by column chromatography over silica gel (eluent:DCM). The pure fractions were collected and the solvent was evaporated. The residue was crystallized from 2-propanol. The precipitate was filtered off and dried, yielding 1 g (26%) of 3-(3-methyl-1,2,4-thiadiazol-5-yl)-6-[[4-[3-(trifluoromethyl)phenoxy]butyl]thio]pyridazine (compound 94).
後処理
- additionwas added
- stirringThe mixture was stirred overnight
- customThe solvent was evaporated
- washThe organic solution was washed with a diluted NaOH solution and with water
- customdried
- filtrationfiltered
- customthe solvent was evaporated
- customThe residue was purified by column chromatography over silica gel (eluent:DCM)
- customThe pure fractions were collected
- customthe solvent was evaporated
- customThe residue was crystallized from 2-propanol
- filtrationThe precipitate was filtered off
- customdried
出典と根拠
- ORDレコード
- ord-81ed27c031b245ae961b0eff76a714a9
- 出典データセット
- uspto-grants-2003_08
- 特許番号
- US06602873B2
反応ノート
読み込み中…